Skip to main content

Table 2 Clinical pathological features related with HSPB1 expression according to logistic regression analysis

From: High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis

Characteristics

Total(N)

Odds Ratio(OR)

P value

Age (> 60 vs. <  = 60)

1,083

1.211 (0.953–1.540)

0.118

T stage (T3&T4 vs. T1&T2)

1,080

1.322 (0.955–1.836)

0.093

N stage (N1&N2&N3 vs. N0)

1,064

1.427 (1.121–1.818)

0.004

M stage (M1 vs. M0)

922

1.625 (0.666–4.182)

0.293

Pathologic stage (Stage III&Stage IV vs. Stage I&Stage II)

1,060

1.516 (1.144–2.014)

0.004

ER status (Positive vs. Negative)

1,033

4.950 (3.561–6.982)

 < 0.001

PR status (Positive vs. Negative)

1,030

2.639 (2.019–3.464)

 < 0.001

HER2 status (Positive vs. Negative)

715

1.136 (0.797–1.620)

0.480

radiation_therapy (Yes vs. No)

987

1.171 (0.910–1.506)

0.219

  1. TMN stage was according to the seventh edition of the Guidelines for the American Journal of Critical Care. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor. Bold values indicate that p < 0.05